Clarus Wealth Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Clarus Wealth Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$13K	–	677
2019 Q1	$13K	Hold	200	–	–	0.01%	489
2018 Q4	$12K	Hold	200	–	–	0.02%	483
2018 Q3	$15K	Buy	200 +50	+33%	+$3.59K	0.01%	481
2018 Q2	$9K	Buy	+150	New	+$9.65K	0.01%	546

Other funds holding PJP

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Clarus Wealth Advisors's PJP Position: Q2 2019 in Review

Clarus Wealth Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2019, closing a stake of 200 shares — an estimated $13K sold.

Clarus Wealth Advisors first reported a position in PJP in Q2 2018 and held it in 4 quarters. The position peaked at $15K in Q3 2018. 83 funds tracked by Wall St. Rank hold PJP as of Q2 2019.

Clarus Wealth Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
Clarus Wealth Advisors sold 200 Invesco Pharmaceuticals ETF shares in Q2 2019, an estimated $13K.
Clarus Wealth Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2018 and held it in 4 quarters.
Clarus Wealth Advisors's Invesco Pharmaceuticals ETF position peaked at $15K in Q3 2018.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2019.

Based on Clarus Wealth Advisors's 13F filing for Q2 2019, filed 24 Jul 2019.